Bilal Muhsin - 01 Jul 2026 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Reporting relationship: EVP & President Connected Care
Issuer ticker: BDX
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2026, 15:16:13 UTC
Prior SEC filing: 01 Dec 2025
Source filing: View source filing
Reporting owner signature: Donna Kalazdy, by power of attorney from Bilal Muhsin

Key filing fact

Bilal Muhsin filed Form 4 for BECTON DICKINSON & CO (BDX) on 06 Jul 2026.

Key facts

This page summarizes Bilal Muhsin's Form 4 filing for BECTON DICKINSON & CO (BDX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2026, 15:16.

Change

Previous filing in this sequence was filed on 01 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001734507 Primary reporting owner

Muhsin Bilal

Relationship: EVP & President Connected Care
Address: C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES
Signature: Donna Kalazdy, by power of attorney from Bilal Muhsin
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDX transaction

Common Stock

Award

Transaction value
Shares: +14,342
Change %: +50%
Price: $0.000000^*
Shares after: 43,294
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F2

BDX transaction

Common Stock

Tax liability

Transaction value
Shares: -1,935
Change %: -4.5%
Price: $0.000000^*
Shares after: 41,359
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Footnote F2

Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.

Footnote F3

Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.